Upcoming events
Early Detection, Better Outcomes: Addressing Unmet Needs in Type 1 Diabetes
4th November 2025Mark your calendar for a high-level event under the Danish Presidency of the Council of the European Union 2025, organised by the Ministry of the Interior and Health of Denmark, the European Diabetes Forum (EUDF), and EDENT1FI. The session will be opened by MEP Stine Bosse and chaired by Prof. Chantal Mathieu. It will bring together policymakers, researchers, clinicians, and people living with type 1 diabetes (T1D) to explore the future of early detection and disease interception in Europe.
Programme highlights include insights from EDENT1FI on early detection across Europe; best practices from Italy; testimonials from individuals and families affected by T1D; perspectives from DiaUnion, the European Association for the Study of Diabetes (EASD), Breakthrough T1D, the Innovative Health Initiative (IHI), and the European Commission; and a roundtable on clinical implementation of disease-modifying therapies.
This event is a unique opportunity to spotlight the power of collaboration in transforming outcomes for people with T1D.
EDENT1FI Annual Meeting 2025 – Prague, Czechia
6th - 8nd October 2025Save the date! The next EDENT1FI Annual Meeting is scheduled from 6 - 8 October 2025 in Prague, hosted by the EDENT1FI partner, University Hospital Motol. We are looking forward to hear the progress of T1D screening in Europe after another year of the project. In addition, we will be updated on the latest developments and findings across all work packages, celebrate major milestones, and set plans for the remaining goals.
ATTD 2026: Diabetes Congress – Barcelona, Spain
11th - 14th March 2026EDENT1FI will be at the 19th edition of the International Conference on Advanced Technologies & Treatments for Diabetes (ATTD). This leading global event brings together clinicians, researchers, industry experts, and innovators to explore the latest breakthroughs in diabetes care. ATTD 2026 will feature cutting-edge research and clinical trial results, AI-powered solutions and next-gen glucose monitoring technologies, ‘The Tech Fair’ showcasing the latest devices and digital health innovations and multiple networking opportunities with global leaders in diabetes technology and treatment. Participants can attend in-person or online, with flexible registration options available. Early bird rates apply until 9 December 2025.
IDS 2026: Brisbane, Australia
20th - 24th April 2026The 21st Immunology of Diabetes Society (IDS) Congress, held jointly with the Australian Islet Study Group Meeting, will take place in Brisbane, Australia. This premier international event brings together researchers, clinicians, industry partners, and people living with type 1 diabetes to share cutting-edge research and foster collaboration across disciplines. The programme will cover the latest advances in T1D pathogenesis, prediction, prevention, and therapeutic innovation.
EDENT1FI partners will be present, contributing to discussions on early screening and immunological insights into type 1 diabetes.
Past events
61st EASD Annual Meeting – Vienna, Austria
15th - 19th September 2025During EASD2025, it was clear: screening for early-stage type 1 diabetes (T1D) is gaining real momentum. We were excited to introduce our new ‘it’s in your hands’ campaign, specifically designed for the general population, to experts, patients, and advocates, and to see so much support for early screening.
The scientific programme featured several sessions focused on early-stage T1D, including an EASD e-Learning expert session on early-stage type 1 diabetes, and the Camillo Golgi Lecture, which addressed screening to detect early-stage T1D and the challenges of prevention and care. In ‘The emerging consensus for population level screening to detect early stage type 1 diabetes’, EDENT1FI coordinators Prof. Anette-Gabriele Ziegler and Prof. Chantal Mathieu talked about the future of population-level screening for early-stage type 1 diabetes. Other discussions explored the importance of emerging screening and monitoring guidelines for early T1D, the role of autoantibodies, continuous glucose monitoring (CGM), and AI in diabetes care, highlighting the growing interest in scalable, tech-enabled screening pathways.
Policy Breakfast at the European Parliament
15th May 2025On May 15, the management team of EDENT1FI partnered up with the European Diabetes Forum (EUDF) and Esperia Advocacy for a ‘Policy Breakfast’ held at the European Parliament in Brussels. At the Breakfast, hosted by the MEP Dario Nardella, participants shared their vision on the importance of early detection of T1D and of health education. We found consensus on the need to reach harmonization among European Member States on public health investments and on the promotion of an equitable access to T1D care and to certified, quality technologies. Overall, the event was a stimulating occasion to strengthen dialogue between science, policy and practice.
ATTD 2025 – Amsterdam, The Netherlands
19th - 22nd March 2025From 19 – 22 March 2025, EDENT1FI will be present at the 18th international conference on Advanced Technologies and Treatments for Diabetes (ATTD). ATTD focuses on pioneering technologies and therapies for diabetes management, providing insights into the latest research, devices, and developments in the field. The conference gathers a diverse group of clinicians, diabetes care providers, researchers, industries, investors, reimbursement authorities, and people with diabetes, fostering the ideal target group to create awareness on the EDENT1FI project.
The BR1DGE Summit 2025 – Barcelona, Spain
17th - 18th February 2025BR1DGE is a global medical education program developed by Sanofi to enhance understanding of presymptomatic T1D. This initiative offers expert-led educational content focusing on the early stages of autoimmune T1D, aiming to transform how the disease is screened, monitored, and managed. During the BR1DGE Summit, Sanofi aims to connect multiple T1D concepts and communities, to explore the transforming field of T1D healthcare. The EDENT1FI project will be highly present in the meeting’s program, with multiple partners giving an oral presentation.
European alliance to overcome diabetes – European Parliament, Brussels, Belgium
12th December 2024EDENT1FI and European Diabetes Forum (EUDF) are joining forces in the European Alliance to Overcome Diabetes. This public event, organized by Esperia Advocacy, features a European call to boost early detection of type 1 diabetes. It will provide an opportunity to report on the progress of Italy’s pioneering work in pediatric screening, and to engage in a constructive dialogue with experts and representatives of the main European associations and scientific societies.
EDENT1FI Annual Meeting - Paris, France
19th - 20th November 2024Mark your calendars! The upcoming EDENT1FI Annual Meeting is scheduled for 19-20 November 2024 at Necker Children’s Hospital in Paris, hosted by EDENT1FI Partner, Sanofi. This event offers a unique opportunity to explore the latest developments and exciting findings across all Work Packages, align on progress, engage in brainstorming and discussions, celebrate both major milestones and small wins, and set plans for a promising future.
IDS 2024 - Bruges, Belgium
4th - 8th November 2024From November 4-8, EDENT1FI was showcased at the IDS Conference in Bruges, where we connected with the global diabetes research community from our booth. The EDENT1FI project focuses on advancing early screening and prevention of type 1 diabetes across Europe through a multi-disciplinary approach. Our work was also represented through an abstract selected for poster presentation, underscoring EDENT1FI’s commitment to innovation in T1D detection and care.
ISPAD 2024 - Lisbon, Portugal
16th - 19th October 2024In Lisbon from October 16-19, 2024, EDENT1FI had fantastic visibility at the 50th ISPAD Conference! Our booth was buzzing with pediatric diabetes specialists and advocates eager to learn about our approach to early screening. The poster presentation gave us even more reach, showcasing EDENT1FI’s commitment to early detection and better care for young people at risk of T1D. We came away with invaluable insights and strengthened partnerships that bring us closer to transforming T1D care across Europe.
EASD 2024 - Madrid, Spain
10th - 13th September 2024At the 60th Annual Meeting of the European Association for the Study of Diabetes (EASD) in Madrid from September 9-13, 2024, EDENT1FI had the chance to connect with global diabetes experts and dive into discussions around early T1D screening. Our booth was a hub for meaningful exchanges on innovative ways to reshape screening practices across Europe. It was inspiring to share our mission with so many in the diabetes research community and build connections that will drive our work forward.
